LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients.

Özdemir, İbrahim Halil / Özlek, Bülent / Özen, Mehmet Burak / Gündüz, Ramazan / Çetin, Nurullah / Özlek, Eda / Yıldız, Bekir Serhat / Bilge, Ali Rıza

Clinical and experimental hypertension (New York, N.Y. : 1993)

2021  Volume 43, Issue 7, Page(s) 683–689

Abstract: ... protein/albumin ratio and the prognosis of hypertensive COVID-19 patients.: Methods: It was designed ... divided into two groups as survivor and non-survivor. C-reactive protein/albumin (CAR) ratios ... as a single center retrospective study. PCR positive COVID-19 patients who were followed up ...

Abstract Objectives: The aim of this study was to investigate the relationship between the C-reactive protein/albumin ratio and the prognosis of hypertensive COVID-19 patients.
Methods: It was designed as a single center retrospective study. PCR positive COVID-19 patients who were followed up in the intensive care unit (ICU) and received antihypertensive treatment were included in the study. The patients were divided into two groups as survivor and non-survivor. C-reactive protein/albumin (CAR) ratios of the patients were compared. The cut-off value was determined as a mortality predictor. The effect of CAR on mortality was evaluated using Logistic Regression analysis.
Results: 281 patients were included in the study. Groups consisted of 135 (non-survivor) and 146 (survivor) patients. CAR was significantly higher in the non-survivor group (p<0.001). The area under the ROC curve for CAR for mortality was 0.807, with sensitivity of 0.71 and specificity of 0.71. The cut-off value for CAR was calculated as 56.62. In logistic regression analysis, CAR increases mortality 4.9 times compared to the cut-off value.
Conclusion: CAR is a powerful and independent prognostic marker for predicting mortality and disease progression in hypertensive COVID-19 patients.
MeSH term(s) C-Reactive Protein/analysis ; COVID-19/complications ; COVID-19/diagnosis ; Humans ; Hypertension/diagnosis ; Hypertension/virology ; Prognosis ; Retrospective Studies ; Serum Albumin, Human
Chemical Substances C-Reactive Protein (9007-41-4) ; Serum Albumin, Human (ZIF514RVZR)
Language English
Publishing date 2021-07-05
Publishing country England
Document type Journal Article
ZDB-ID 604757-9
ISSN 1525-6006 ; 0730-0077
ISSN (online) 1525-6006
ISSN 0730-0077
DOI 10.1080/10641963.2021.1937205
Shelf mark
Zs.A 1429: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top